FeesSafety
Pluang+

Chatham Lodging Trust's preferred stock yields 8.71% but carries higher risk amid rising rates.

Company Fundamentals
06 Oct 2026, 21:38 WIB
Seeking Alpha
View Source
Neutral
Chatham Lodging Trust's preferred stock yields 8.71% but carries higher risk amid rising rates.

Chatham Lodging Trust (CLDT) maintains a solid balance sheet with a Moody's implied Baa2 investment-grade rating, but its adjusted credit rating is Ba1 due to sector cyclicality and high interest rates, indicating elevated risk. The company's preferred stock, CLDT.PR.A, offers a high yield of 8.71% but has an implied Ba3 rating, which is riskier compared to investment-grade REIT preferred shares. In the current environment of rising interest rates, safer investment opportunities exist in officially investment-grade REIT preferred stocks. Investors should weigh the higher yield against the increased credit risk before investing in CLDT preferred shares.

Chatham Lodging Trust preferred shares offer a high yield of 8.71%, indicating elevated risk in the current credit environment. For readers following the real estate sector, here is Pluang's market snapshot as of Oct 06, 2026 23:33 WIB: out of 26 priced US real estate stocks, 21 rose and 5 fell today. Notable movers include Orion Office REIT Inc (ONL) at USD 2.39 with a 1-day change of +1.27% and 100% sell order activity, Crown Castle International Corp (CCI) at USD 68.43 with a 1-day change of +1.26% and 100% sell order activity, and ARMOUR Residential REIT, Inc. (ARR) at USD 13.37 with a 1-day change of -1.18% and 61% buy order activity.

More News

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

The global brain cancer diagnostics market is projected to grow from USD 4.1 billion in 2025 to USD 9.85 billion by 2034, at a CAGR of about 10.2%. Growth is fueled by increasing brain tumor incidence, adoption of advanced imaging and molecular diagn...

Bullish
33 minutes ago
Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google initially launched its first Project Suncatcher AI satellite with SpaceX but has now signed a launch agreement with Blue Origin for a dedicated mission in early 2029. This shift comes amid SpaceX's threat to halt future Falcon 9 commercial lau...

Market News
Bullish
35 minutes ago
Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe leads in creative software with strong revenue growth and a new AI partnership with Disney, offering stable long-term prospects despite management changes. Synopsys excels in semiconductor design tools, boosted by its Ansys acquisition and expa...

Bullish
36 minutes ago
Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's net income for the trailing 12 months has surged to around $19.4 billion, more than four times its level in June, while its stock price has fallen to about a third of its June peak. This drop means the stock now trades at roughly 6 times ea...

Market News
Bullish
37 minutes ago
Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex Pharmaceuticals is poised for growth with potential FDA approval of povetacicept for kidney disease and a strong cystic fibrosis drug franchise, alongside a $10 billion acquisition expanding its pipeline. Regeneron is thriving with Dupixent's ...

Market News
Bullish
50 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App